XML 32 R18.htm IDEA: XBRL DOCUMENT v3.3.1.900
Common Stock Placements
 12 Months Ended
Dec. 31, 2015
Stockholders' Equity Note [Abstract]  
Common Stock Placements
Common Stock Placements
Public Offering of Common Stock
In December of 2013, the Company completed a public offering (the "Offering”) of 5,750,000 shares of its common stock at $6.80 per share. Proceeds from the Offering, net of underwriting expenses were $36,704,000. In addition, the Company incurred approximately $194,000 in various legal fees for services related to the Offering.
Proceeds from the Offering were used for general corporate purposes, including, but not limited to, research, development and further commercialization of our products, obtaining regulatory approvals, funding of our clinical trials, capital expenditures, working capital and future acquisitions of complementary businesses, technology or products.